Enliven Therapeutics Inc. (ELVN)

AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

undefined

undefined%

At close: undefined

23.15

-0.43%

After-hours Dec 13, 2024, 04:00 PM EST

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.

Boring Mode

Year	FY23	FY22	FY21	FY20	FY19	FY18	FY17
Revenue	-	-	-	-	-	-	-
Cost of Revenue	297.00K	622.00K	99.00K	97.00K	33.00K	-	-
Gross Profit	-297.00K	-622.00K	-99.00K	-97.00K	-33.00K	-	-
Operating Income	-83.53M	-38.79M	-24.76M	-9.32M	-24.12M	-10.68M	-8.90M
Interest Income	11.97M	1.13M	22.00K	31.00K	578.00K	-	-
Pretax Income	-71.58M	-37.66M	-24.74M	-18.97M	-23.46M	-11.34M	221.00K
Net Income	-71.58M	-37.75M	-24.72M	-18.93M	-23.46M	-11.34M	-
Selling & General & Admin	18.95M	7.77M	4.29M	1.08M	5.07M	2.44M	987.00K
Research & Development	64.57M	31.02M	20.47M	8.24M	19.01M	8.24M	7.92M
Other Expenses	-	-	-	-9.68M	-	-	-
Operating Expenses	83.53M	38.79M	24.76M	9.32M	24.08M	10.68M	8.90M
Interest Expense	-	-	-	-	-	-	-
Selling & Marketing Expenses	-	-	-	-	-33.00K	-	-
Cost & Expenses	83.53M	38.79M	24.76M	9.32M	24.12M	10.68M	8.90M
Income Tax	-	88.00K	-22.00K	-31.00K	653.00K	-821.14K	221.00K
Shares Outstanding (Basic)	35.55M	6.25M	7.81M	3.48M	4.32M	4.32M	4.32M
Shares Outstanding (Diluted)	35.55M	6.25M	7.81M	3.48M	4.32M	4.32M	4.32M
EPS (Basic)	-2.01	-6.03	-3.17	-14.14	-5.43	-2.62	-
EPS (Diluted)	-2.01	-6.03	-3.17	-14.14	-5.43	-2.62	-
EBITDA	-81.93M	-38.58M	-24.65M	-9.27M	-23.43M	-11.34M	221.00K
Depreciation & Amortization	297.00K	215.00K	115.00K	97.00K	33.00K	-660.00K	-